WAY-132983

N/A

Report date: 2022/05/05 15:48:16

Base Information

Drug NameWAY-132983
Drug Alias NameWAY-132983
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 agonists
TargetsMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Holdings LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Holdings LLC
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A